Moen, Marit D <br/><br/>
Spotlight on denosumab in postmenopausal osteoporosis.  [electronic resource] 

 -  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy  Aug 2011 
 - 261-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-190X 
<br/><br/><label>Standard No.: </label>10.2165/11207100-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--economics<br/>Antibodies, Monoclonal, Humanized<br/>Bone Density--drug effects<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Denosumab<br/>Female<br/>Fractures, Bone--drug therapy<br/>Humans<br/>Osteoporosis, Postmenopausal--drug therapy<br/>RANK Ligand--economics<br/>Randomized Controlled Trials as Topic